Latest news
AbbVie’s Skyrizi retakes edge in pharma’s July ad spending league - Fierce PharmaFierce Pharma · Fri, 07 Aug 2026 13:45:00 GMTNovo Nordisk makes Omnicom agency of record for US media buying - Fierce PharmaFierce Pharma · Fri, 07 Aug 2026 13:44:19 GMTFresenius Kabi recalls morphine lot that could lead to death - Fierce PharmaFierce Pharma · Fri, 07 Aug 2026 13:29:33 GMTFierce Pharma Asia—Takeda’s historic narcolepsy nod; Daiichi’s accounting error; Astellas’ revenue beat - Fierce PharmaFierce Pharma · Fri, 07 Aug 2026 12:35:10 GMTVerilyMe, Bausch + Lomb visualize dry eye education in new collaboration - Fierce PharmaFierce Pharma · Fri, 07 Aug 2026 01:35:43 GMTUPDATED: Replimune secures FDA approval for melanoma therapy Tudriqev after long regulatory battle - Fierce PharmaFierce Pharma · Thu, 06 Aug 2026 20:41:48 GMTSarepta’s new CEO Michael Severino faces critical milestones to prove growth - Fierce PharmaFierce Pharma · Thu, 06 Aug 2026 15:15:32 GMTTakeda gains FDA nod for first-in-class narcolepsy treatment Orzeyful - Fierce PharmaFierce Pharma · Thu, 06 Aug 2026 15:10:41 GMT